Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TECH
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne (TECH) trades at $71.77, down slightly by 0.01% on the day, with a bullish technical signal from moving averages and a pending acquisition by Merck KGaA at $73 per share announced on June 25, 2026. The company reported mixed quarterly earnings, with a Q1 2026 EPS miss but a Q4 2025 beat, while valuation ratios like P/E of 102.54 remain elevated. Cash flow improved in 2025 with net cash flow of $10.40 million, and a dividend of $0.08 was declared for May 2026.
The outlook is heavily influenced by the proposed acquisition, offering a near-term upside to the $73 bid. Risks include shareholder litigation over deal fairness and margin compression from a net income drop to $73.40 million in 2025. Analysts are split evenly between Buy and Hold ratings, with a consensus price target of $67.75 below the current price, suggesting caution amid acquisition uncertainty.
Read full analysis

Key Stats

  • Market Cap
    $11.18B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $72.12
  • 52W Low
    $43.31
  • Typical Hold Time
    -
  • Enterprise Value
    $11.26B
  • Div Yield
    0.45%
  • Trading Activity
    -
$71.6
52W Low: $43.31
15 May 2026
52W High: $72.12
17 Jul 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.12, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

Oportun named to CNBC's Top Fintech Companies 2026 list for third year in a row.

Oportun Financial Corporation has been recognized on CNBC's World's Top Fintech Companies 2026 list for the third consecutive year, highlighting its impact in the Wealth Technology category. The company is praised for its technology-driven tools that...

Market News
4 hours ago
Not Specified
Bullish
news icon
pluang ai news

Class action lawsuit filed against PROCEPT BioRobotics over alleged misleading sales and inventory practices.

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation and its executives, accusing them of misleading investors by inflating sales figures through an undisclosed discount program that caused excess ...

Market News
4 hours ago
Robbins Geller Rudman & Dowd Llp
Bearish
news icon
pluang ai news

Class action lawsuit filed against Cogent Communications over misleading backlog and financial claims

Rosen Law Firm has filed a class action lawsuit on behalf of Cogent Communications stock purchasers from Feb 29, 2024 to May 1, 2026. The suit alleges Cogent misled investors by overstating its optical wavelength backlog, customer demand, and financi...

Market News
5 hours ago
PRNewsWire
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.18B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $72.12
  • 52W Low
    $43.31
  • Typical Hold Time
    -
  • Enterprise Value
    $11.26B
  • Div Yield
    0.45%
  • Trading Activity
    -
$71.6
52W Low: $43.31
15 May 2026
52W High: $72.12
17 Jul 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.12, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!